Condition
Hereditary Breast Cancer
Total Trials
5
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Active Not Recruiting1
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07307664Not ApplicableRecruiting
Increasing Germline Genetic Testing for Patients With Cancer
NCT04197856Not ApplicableActive Not Recruiting
Direct Information to At-risk Relatives
NCT03959267Not ApplicableCompleted
Testing a Culturally Adapted Telephone Genetic Counseling Intervention
NCT02557776Not ApplicableCompletedPrimary
Written Genetic Counseling and Mutation Analysis of BRCA1 and BRCA2 to Patients With Breast Cancer
NCT03495544UnknownPrimary
Study Estimating Association Between Germline Mutations and PD-L1 Expression in Breast Cancer
Showing all 5 trials